Crescent Energy Company
CRGY
$15.37
+5.35%
Crescent Energy Company is an independent energy company engaged in the exploration and production of crude oil, natural gas, and natural gas liquids, operating a long-life, balanced portfolio that combines stable, low-decline production with a deep inventory of development opportunities. The company positions itself as an acquisition-driven consolidator in the U.S. upstream space, using disciplined M&A and consistent capital returns to differentiate itself from pure-play drillers. The current investor narrative centers on a powerful operational turnaround: after a loss-making 2024 and a difficult first half of 2025, Crescent has swung back to positive quarterly earnings, delivered strong free cash flow, and seen its shares rally sharply as investors re-rate the story toward capital discipline and shareholder returns. With a dividend yield above 5% and a buy-rated analyst consensus, the debate now hinges on whether the company can sustain its production base and cash generation while continuing to integrate acquisitions and manage a leveraged balance sheet.…
CRGY
Crescent Energy Company
$15.37
Investment Opinion: Should I buy CRGY Today?
Based on the synthesized data, CRGY warrants a Buy rating for value-oriented investors with a tolerance for commodity price volatility. The core thesis is that Crescent is a deeply undervalued, cash-generative E&P consolidator trading at a forward PE of 6.54x and an EV/EBITDA of 4.64x, with a Buy-rated analyst consensus (mean 1.75) and an average target price of $16.19 implying 10.4% upside. The recent swing to positive operating income of $327.5 million in Q1 2026 and trailing FCF of $374.0 million (18.4% yield) support the view that the market is overly pessimistic about execution risk.
Supporting evidence includes: (1) revenue growth of 24.49% year-over-year in Q1 2026 to $1.183 billion, driven by acquisitions; (2) a dividend yield of 5.67%, well above the sector average, backed by operating cash flow of $409.2 million; (3) a price-to-book of 0.39x, near multi-year lows and a fraction of the sector's 1.5–2.0x; and (4) the forward PE of 6.54x versus a sector average of 10–12x, a 35–45% discount. These metrics suggest the stock is undervalued relative to both its history and peers, assuming oil prices remain stable.
The biggest risks that could invalidate the thesis are: (1) a decline in oil prices that compresses cash flow and forces a dividend cut; (2) failure to integrate acquisitions efficiently, leading to further dilution or asset impairments; and (3) a rise in interest rates that increases borrowing costs and pressures the leveraged balance sheet. The rating would upgrade to Strong Buy if the company reduces debt-to-equity below 0.8 or achieves positive free cash flow in consecutive quarters. It would downgrade to Hold if revenue growth decelerates below 10% or if the dividend payout ratio exceeds 100%. Relative to its own history and peers, CRGY appears undervalued, but the discount reflects legitimate leverage and execution risks.
Sign up to view all
CRGY 12-Month Price Forecast
Crescent Energy presents a compelling value opportunity with a forward PE of 6.54x and an 18.4% free cash flow yield, significantly below sector averages. The company's recent swing to positive operating income and strong revenue growth support the bull case, while the leveraged balance sheet and negative quarterly free cash flow pose risks. The analyst consensus is bullish, but the wide target range ($12–$20) reflects uncertainty. I would upgrade to high confidence if the company demonstrates two consecutive quarters of positive free cash flow and reduces debt-to-equity below 0.9. Conversely, a downgrade to neutral would occur if oil prices fall below $65/bbl or if the dividend payout ratio exceeds 100%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crescent Energy Company's 12-month outlook, with a consensus price target around $16.94 and implied upside of +10.2% versus the current price.
Average Target
$16.94
0 analysts
Implied Upside
+10.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$12 - $21
Analyst target range
Crescent Energy is covered by 16 analysts, and the consensus is decidedly bullish. The recommendation mean is 1.75 (on a scale where 1 is Strong Buy and 5 is Sell), corresponding to a "Buy" rating. The average target price is $16.19, which implies approximately 10.4% upside from the current price of $14.66. The consensus leans bullish, with recent institutional ratings showing a preponderance of Overweight and Strong Buy ratings from firms including Raymond James (Strong Buy), Wells Fargo (Overweight), Piper Sandler (Overweight), KeyBanc (Overweight), and Stephens & Co. (Overweight), with only Mizuho maintaining a Neutral stance. The estimated EPS average of $2.02 for the forward year supports the bullish case, as it implies a forward PE of just 6.54x.
The target price range is wide, from a low of $12.00 to a high of $20.00, a spread of 66.7% relative to the low target. The high target of $20.00 assumes a successful integration of acquisitions, sustained oil prices, and a re-rating of the multiple toward the sector average, potentially driven by continued debt reduction and dividend growth. The low target of $12.00, which is below the current price, prices in a scenario of margin compression, weaker commodity prices, or execution missteps that could pressure cash flow and force a reduction in capital returns. The wide spread signals meaningful uncertainty, but the clustering of ratings at Overweight/Strong Buy and the recent upward momentum suggest that analysts are generally aligned on the positive trajectory. Notably, there have been no downgrades in the recent ratings history, and Johnson Rice upgraded from Buy to Accumulate in March 2026, reinforcing the constructive sentiment. The short ratio of 5.35 days adds a layer of potential volatility, as a squeeze could accelerate upside if the stock breaks above resistance.
Bulls vs Bears: CRGY Investment Factors
The bull case for CRGY rests on its deep value multiples, exceptional free cash flow yield, and strong operational turnaround, supported by a Buy-rated analyst consensus and significant relative strength. The bear case centers on the leveraged balance sheet, negative quarterly free cash flow, earnings volatility from non-cash charges, and dilution from acquisitions. Currently, the bull evidence appears stronger: the forward PE of 6.54x and FCF yield of 18.4% are compelling, and the recent swing to positive operating income suggests the core business is healthy. However, the single most important tension is whether Crescent can sustain its production base and cash generation while integrating acquisitions and managing debt—if oil prices weaken or integration stumbles, the high leverage could force a dividend cut or asset sales, severely undermining the thesis. Conversely, successful integration and debt reduction could catalyze a re-rating toward sector multiples, unlocking substantial upside.
Bullish
- Deep Value Multiples vs. Sector: CRGY trades at a forward PE of 6.54x and EV/EBITDA of 4.64x, both well below the typical E&P range of 10–12x and 5–7x respectively. The price-to-book of 0.39x is a fraction of the sector's 1.5–2.0x norm, implying the market is pricing in severe execution risk that may not materialize.
- Explosive Free Cash Flow Yield: Trailing twelve-month free cash flow of $374.0 million against a market cap of $2.03 billion yields roughly 18.4%, one of the highest in the upstream space. This cash generation supports a 5.67% dividend yield and provides ample capacity for debt reduction or accretive acquisitions.
- Strong Momentum and Relative Strength: The stock has gained 72.27% year-to-date and 66.59% over the past year, crushing the S&P 500's 12.08% and 16.22% respective gains. Relative strength of 60.19% YTD and 22.62% over the past month signals persistent company-specific catalysts, likely the swing to positive operating income and strong cash flow.
- Analyst Consensus Buy with Upside: 16 analysts cover CRGY with a recommendation mean of 1.75 (Buy), and an average target price of $16.19 implies 10.4% upside from $14.66. The high target of $20.00 suggests 36.4% upside if the company successfully integrates acquisitions and re-rates toward sector multiples.
Bearish
- Leveraged Balance Sheet Constrains Flexibility: Debt-to-equity stands at 1.11, and interest expense was $104.6 million in Q1 2026 alone, consuming a significant portion of operating cash flow. The current ratio of 1.48 provides adequate short-term liquidity but leaves little room for error if oil prices decline.
- Negative Free Cash Flow in Q1 2026: Despite strong trailing FCF, Q1 2026 free cash flow was negative at -$263.0 million due to a $672.2 million capital expenditure program. This growth spending outpaced operating cash flow of $409.2 million, creating dependence on external financing or asset sales.
- Earnings Volatility and Non-Cash Charges: Q1 2026 reported a net loss of -$419.8 million (EPS -$1.28) due to an $828.9 million non-cash other expense, highlighting the unpredictability of reported earnings. The trailing PE of 15.54x is distorted by these charges, and the PEG ratio of -0.096 is meaningless given the negative earnings growth base.
- Acquisition-Driven Share Dilution: Diluted shares outstanding jumped from 254.6 million in Q3 2025 to 328.3 million in Q1 2026, a 29% increase, reflecting acquisition-driven growth rather than organic expansion. This dilution pressures per-share metrics and ROE, which is a low 2.58%.
CRGY Technical Analysis
Crescent Energy is in a powerful, sustained uptrend. The stock has gained 66.59% over the past year and 72.27% year-to-date, dramatically outperforming the S&P 500's 16.22% and 12.08% respective gains, with relative strength of 50.37% over one year and 60.19% YTD. At a current price of $14.66, the shares are trading at approximately 99.9% of their 52-week range (52-week low of $7.68 and high of $14.67), meaning the stock is effectively at its 52-week high — a positioning that signals strong momentum but also raises the risk of near-term overextension and profit-taking.
Short-term momentum is accelerating and confirms the longer-term trend. The stock is up 21.56% over the past month and 26.60% over three months, with the one-month gain outpacing the three-month gain, indicating that momentum is strengthening rather than fading. This is especially notable because the S&P 500 fell 1.06% over the same one-month period, producing a relative strength of 22.62% — a massive divergence that suggests company-specific catalysts, likely the swing to profitability and strong free cash flow, are driving the move. The 6-month change of 22.27% and YTD gain of 72.27% show the rally has been persistent rather than a single spike, though the short ratio of 5.35 days indicates elevated short interest that could fuel further squeezes or add volatility on any negative surprise.
Key technical levels are well defined. Immediate resistance sits at the 52-week high of $14.67, just above the current $14.66 price; a decisive breakout above this level on strong volume would signal continuation of the uptrend and likely open the door to the analyst high target of $20.00. Support is anchored at the 52-week low of $7.68, with intermediate support likely around the $11.50–$12.00 area where the stock consolidated in June and July. The beta of 0.917 indicates the stock is slightly less volatile than the broader market, which is unusual for an E&P name and suggests the recent rally has been driven by idiosyncratic fundamentals rather than pure beta exposure; however, the max drawdown of -34.34% over the past year is a reminder that this name can still experience sharp reversals, making position sizing and stop discipline important.
Beta
0.92
0.92x market volatility
Max Drawdown
-34.3%
Largest decline past year
52-Week Range
$8-$15
Price range past year
Annual Return
+82.5%
Cumulative gain past year
| Period | CRGY Return | S&P 500 |
|---|---|---|
| 1m | +26.0% | -2.4% |
| 3m | +42.6% | +2.2% |
| 6m | +25.5% | +14.8% |
| 1y | +82.5% | +14.6% |
| ytd | +80.6% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRGY Fundamental Analysis
Crescent's revenue trajectory is growing but lumpy. The most recent quarter (Q1 2026, ended 2026-03-31) reported revenue of $1.183 billion, up 24.49% year-over-year from $950.2 million in Q1 2025. However, the multi-quarter trend is uneven: revenue rose from $866.6 million in Q3 2025 to $865.0 million in Q4 2025 before jumping to $1.183 billion in Q1 2026, a sequential increase of roughly 36.8%. The Q1 2026 revenue surge was accompanied by a sharp increase in share count (328.3 million diluted shares vs. 254.6 million in Q3 2025), pointing to acquisition-driven growth rather than purely organic expansion. Segment data shows natural gas production revenue of $158.4 million and midstream/other revenue of $6.0 million, indicating the company remains predominantly oil-weighted, which ties its fortunes closely to crude prices.
Profitability has swung sharply back into positive territory after a loss-making 2024. Q1 2026 net income was -$419.8 million (EPS of -$1.28), but this loss was driven almost entirely by a massive $828.9 million non-cash other expense (likely a derivative or impairment charge), as operating income was actually positive at $327.5 million with an operating margin of 27.69%. The trailing twelve-month picture is more representative: net margin is 3.71%, operating margin is 13.23%, and gross margin is 22.58%. The quarterly gross margin of 91.37% in Q1 2026 is anomalously high due to the classification of certain costs, but the more normalized gross margin in prior quarters (18.4% in Q4 2025, 81.1% in Q3 2025) reflects the volatility inherent in E&P accounting. The key takeaway is that the core business is generating positive operating income, and the reported net loss is largely a function of non-cash items rather than operational weakness.
Balance sheet and cash flow metrics reveal a leveraged but cash-generative business. Debt-to-equity stands at 1.11, and the current ratio is 1.48, indicating adequate short-term liquidity but a meaningful debt load. Free cash flow on a trailing twelve-month basis is $374.0 million, which against a market cap of $2.03 billion implies an FCF yield of roughly 18.4% — a very high yield that underscores the cash-generating power of the asset base. However, Q1 2026 free cash flow was negative at -$263.0 million due to a $672.2 million capital expenditure program, and the company paid $39.3 million in dividends during the quarter. ROE is low at 2.58% and ROA at 3.07%, reflecting the capital-intensive nature of the business and the dilutive effect of acquisitions. The company relies on operating cash flow ($409.2 million in Q1 2026) to fund its capex and dividends, but the negative free cash flow in the quarter shows that growth spending can outpace internal cash generation, creating dependence on external financing or asset sales.
Quarterly Revenue
$1.2B
2026-03
Revenue YoY Growth
+24.5%
YoY Comparison
Gross Margin
91.4%
Latest Quarter
Free Cash Flow
$373978000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRGY Overvalued?
Because Crescent reported positive trailing net income (EPS of $0.065), the PE ratio is the primary metric, though it must be interpreted with caution given the volatility of earnings. The trailing PE is 15.54x, while the forward PE is just 6.54x based on estimated EPS of $2.02. This enormous gap — forward earnings are expected to be roughly 30x trailing earnings — implies the market is pricing in a dramatic earnings recovery, likely driven by the normalization of non-cash charges and the full contribution of recent acquisitions. The PEG ratio of -0.096 is not meaningful given the negative earnings growth base, and the PS ratio of 0.57x and EV/Sales of 2.25x provide additional context for a company with a 3.71% net margin.
Relative to the broader Energy sector, Crescent screens as deeply undervalued on most metrics. The price-to-book ratio of 0.39x is a fraction of the sector's typical 1.5–2.0x range, and the PS ratio of 0.57x is well below the sector average of roughly 1.5–2.0x. The EV/EBITDA of 4.64x is also below the typical E&P range of 5–7x. This discount likely reflects the company's higher leverage (debt-to-equity of 1.11), its acquisition-heavy growth model, and the lumpiness of its earnings. However, the forward PE of 6.54x versus a sector average of roughly 10–12x represents a 35–45% discount, which appears excessive given the company's strong free cash flow generation and 5.67% dividend yield. The market appears to be pricing in significant execution risk that may not be warranted if the company can sustain its production and cash flow.
Historically, Crescent's valuation has been volatile. The PE ratio ranged from negative territory in loss-making quarters to as high as 23.7x in Q2 2023, while the PS ratio has ranged from roughly 2.4x to 4.9x over the past three years. The current PS ratio of 0.57x is near the low end of its historical band, and the PB ratio of 0.39x is also near multi-year lows (compared to 0.95x in Q1 2026 and 2.36x in Q4 2022). This suggests that either the market is pricing in a pessimistic scenario for oil prices and execution, or the stock is genuinely undervalued relative to its own history. Given the recent rally, the low multiples are partly a function of the share count increase from acquisitions, but the forward PE of 6.54x still implies a compelling value proposition if earnings estimates are met.
PE
15.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 1x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.6x
Enterprise Value Multiple
Investment Risk Disclosure
Crescent Energy faces significant financial and operational risks stemming from its leveraged balance sheet and acquisition-heavy strategy. Debt-to-equity of 1.11 and interest expense of $104.6 million in Q1 2026 consume a substantial portion of operating cash flow, leaving limited cushion if commodity prices decline. The company's Q1 2026 free cash flow was negative at -$263.0 million due to a $672.2 million capex program, highlighting that growth spending can outpace internal cash generation. Additionally, revenue is predominantly oil-weighted, with natural gas contributing only $158.4 million in Q1 2026, making cash flow highly sensitive to crude price fluctuations. The 29% increase in diluted shares from Q3 2025 to Q1 2026 dilutes per-share metrics and pressures ROE, which stands at a low 2.58%.
Market and competitive risks include valuation compression if the company fails to meet its forward EPS estimate of $2.02, which underpins the 6.54x forward PE. The stock's beta of 0.917 suggests it is slightly less volatile than the market, but the max drawdown of -34.34% over the past year demonstrates susceptibility to sharp reversals. The energy sector is subject to regulatory headwinds, including potential environmental restrictions on fossil fuel production, and macro sensitivity to oil prices driven by global supply-demand dynamics. With no recent news provided, the risk of sector rotation away from energy stocks remains, especially if interest rates stay elevated and growth stocks regain favor. The short ratio of 5.35 days indicates bearish sentiment that could exacerbate downside on any operational miss.
In a worst-case scenario, a sustained decline in oil prices below $60 per barrel would compress cash flow, forcing Crescent to cut its dividend (currently yielding 5.67% with a payout ratio of 86.6%) and potentially breach debt covenants. This could trigger a sell-off toward the 52-week low of $7.68, representing a 47.6% decline from the current price of $14.66. The analyst low target of $12.00 implies a 18.1% downside, but in a severe downturn, the stock could retest its historical low. Investors could lose approximately 47.6% from the current price in this adverse scenario, underscoring the importance of position sizing and stop-loss discipline.
FAQ
The most severe risk is financial: debt-to-equity of 1.11 and interest expense of $104.6 million in Q1 2026 leave little cushion if oil prices fall, potentially forcing a dividend cut (payout ratio already 86.6%). Second, operational risk: Q1 2026 free cash flow was negative at -$263.0 million due to heavy capex, and the company relies on external financing to fund growth. Third, market risk: the stock is trading at 99.9% of its 52-week range, and the short ratio of 5.35 days indicates bearish positioning that could amplify a sell-off. Fourth, dilution risk: share count increased 29% from Q3 2025 to Q1 2026, pressuring per-share metrics. These risks are ranked from highest to lowest severity, with the leverage and commodity price sensitivity being the most critical.
Our 12-month forecast assigns a 55% probability to the base case, with a target range of $15–$17, assuming oil prices average $72/bbl and the company meets its forward EPS of $2.02. The bull case (25% probability) targets $18–$20 if oil prices exceed $80/bbl and debt reduction accelerates, while the bear case (20% probability) targets $10–$12 if oil falls below $60/bbl and the dividend is cut. The most likely scenario is the base case, driven by stable oil prices and successful integration of acquisitions. The key assumption is that WTI remains above $70, allowing Crescent to generate sufficient cash flow to cover its dividend and reduce debt gradually.
CRGY appears undervalued on multiple metrics. Its forward PE of 6.54x is a 35–45% discount to the sector average of 10–12x, and its price-to-book of 0.39x is far below the sector's 1.5–2.0x range. The EV/EBITDA of 4.64x is also below the typical E&P range of 5–7x. The market is pricing in significant execution risk and leverage concerns, as evidenced by the low PS ratio of 0.57x. If the company meets its forward EPS estimate of $2.02, the stock could re-rate toward $16–$20, but the discount reflects legitimate balance sheet risks. Relative to its own history, the PS ratio is near multi-year lows, suggesting the stock is undervalued unless oil prices collapse.
CRGY presents a favorable risk/reward for value investors, with a forward PE of 6.54x and an 18.4% free cash flow yield, both well below sector averages. The analyst consensus is Buy with an average target of $16.19, implying 10.4% upside, and the high target of $20.00 suggests 36.4% potential. However, the stock carries significant leverage (debt-to-equity of 1.11) and recently reported negative quarterly free cash flow of -$263.0 million, which could pressure the dividend if oil prices decline. It is a good buy for investors with a medium-to-high risk tolerance and a positive long-term view on oil prices, but position sizing should account for the possibility of a 47.6% drawdown to the 52-week low of $7.68 in a severe downturn.
CRGY is better suited for a medium-to-long-term investment horizon of at least 2–3 years, given its acquisition-driven growth strategy and the cyclical nature of the energy sector. The stock's beta of 0.917 indicates slightly lower volatility than the market, but the max drawdown of -34.34% over the past year shows it can experience sharp reversals. The 5.67% dividend yield provides income, but the high payout ratio of 86.6% means the dividend is not guaranteed. Short-term trading could be profitable given the strong momentum (up 21.56% in one month), but the elevated short interest and overbought technicals increase the risk of a pullback. A minimum holding period of 18–24 months allows time for acquisition integration and potential multiple re-rating.